The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Moderna's updated Spikevax shot includes 25 µg of spike protein mRNA from BA.4/BA.5 and 25 µg from the original strain of SARS-CoV-2, and has been authorised for the over-18s. It has also been ...

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax's updated protein-based vaccine targets the JN.1 subvariant of Omicron ...

1 Omicron subvariant. The Omicron booster made by Pfizer Inc. can be administered to people 12 and older, while Moderna Inc.’s Omicron booster is authorized for those 18 and older. In the past ...

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax's updated protein-based vaccine targets the JN.1 subvariant of Omicron ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

Sneezing, fever, chills, vomiting, coughing — it’s not just one virus wreaking havoc this winter; it’s a combination of four ...

In this study, the authors estimated that Paxlovid reduced the risk of hospitalization by 39% (95% confidence interval [CI], ...